Category: Uncategorized


Ajovy, the Second Drug Targeting CGRP, Receives FDA Approval

        Late on Friday, September 14, 2018, Teva Pharmaceuticals USA, Inc, received approval for fremanezumab vfrm (Ajovy) from the United States Food and Drug Administration (FDA). Ajovy has been approved for the preventative treatment of migraine in adults, and is the first drug targeting CGRP that is available in both quarterly andRead More

About Me

MY STORY Welcome! My name is Anita Liberatore. I am a daughter, sister, friend, wife, and mother of four- two boys, two girls: three adults, one teenager with special needs. I have suffered from migraines since I was five years of age; I have endured chronic migraine for the last ten years or more. IRead More